TrimRX
US$ 26.56
retatrutide phase 2 trial obesity nejm 2023 𧬠R3TA is a next-generation peptide being studied for its unique triple-receptor approach to metabolic health. Unlike traditional GLP-1 therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, GIP Tirzepatide as Compared with Semaglutide
Description
3 Satija, B
Brown RE, Sergeeva OA, Eriksson KS, Haas HL
If weight is coming off consistently, appetite is well controlled and side effects are manageable, there is generally no clinical reason to increase ahead of schedule
I see approximately 7800-10,000 patients per year
10.1124/mol.104.004465 134 StoccoroA.SicilianoG.MiglioreL.CoppedeF
Stevens, Radostin Danev, Denise Wootten and Patrick M
